Highlights
KLSE: BIOHLDG (0179)       BIOALPHA HOLDINGS BHD ACE : Consumer
Last Price Today's Change   Day's Range   Trading Volume
0.215   +0.005 (2.38%)  0.21 - 0.22  2,840,800
Trade this stock and receive a FREE I3investor T-shirt after 5 trades. Find out more.

Financials


Market Cap: 29 Million

Market Cap 29 Million
NOSH 134 Million

Latest Audited Result:  31-Dec-2020

Latest Audited Result: 31-Dec-2020
Announcement Date 27-May-2021
Next Audited Result: 31-Dec-2021
Est. Ann. Date: 27-May-2022
Est. Ann. Due Date: 29-Jun-2022

Latest Quarter:  31-Mar-2021 [#1]

Latest Quarter: 31-Mar-2021 [#1]
Announcement Date 27-May-2021
Next Quarter: 30-Jun-2021
Est. Ann. Date: 28-Aug-2021
Est. Ann. Due Date: 29-Aug-2021
QoQ | YoY   110.71%  |    127.22%

Annual (Unaudited) ( EPS: -28.16, P/E: -0.76 )

Revenue | NP to SH 36,515  |  -37,781
RPS | P/RPS 27.21 Cent  |  0.79
EPS | P/E | EY -28.16 Cent  |  -0.76  |  -130.96%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 1.18  |  0.18
YoY   -516.92%
NP Margin | ROE -106.52%  |  -23.94%
F.Y. | Ann. Date 31-Dec-2020  |  02-Mar-2021

T4Q Result ( EPS: -22.45, P/E: -0.96 )

Revenue | NP to SH 54,767  |  -30,128
RPS | P/RPS 40.81 Cent  |  0.53
EPS | P/E | EY -22.45 Cent  |  -0.96  |  -104.43%
DPS | DY | Payout % 0.00 Cent  |  0.00%  |  - %
NAPS | P/NAPS 1.20  |  0.18
QoQ | YoY   18.86%  |    -1,228.81%
NP Margin | ROE -58.20%  |  -18.71%
F.Y. | Ann. Date 31-Mar-2021  |  27-May-2021

Annualized Result ( EPS: 4.47, P/E: 4.81 )

Revenue | NP to SH 99,132  |  5,992
RPS | P/RPS 73.88 Cent  |  0.29
EPS | P/E | EY 4.47 Cent  |  4.81  |  20.77%
DPS | DY | Payout % -
NAPS | P/NAPS -
QoQ | YoY   115.86%  |    127.22%
NP Margin | ROE 5.83%  |  3.72%
F.Y. | Ann. Date 31-Mar-2021  |  27-May-2021


Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.

Click here to modify the Visible Columns.

Date Financial Result Financial Ratio Per Share Item Performance Valuation (End of Quarter) Valuation (Ann. Date)
F.Y. Ann. Date Quarter # Revenue PBT NP NP to SH Div Net Worth Div Payout % NP Margin ROE NOSH RPS Adj. RPS EPS Adj. EPS DPS Adj. DPS NAPS Adj. NAPS QoQ YoY EOQ Date EOQ Price EOQ P/RPS EOQ P/EPS EOQ P/NAPS EOQ EY EOQ DY ANN Date ANN Price ANN P/RPS ANN P/EPS ANN P/NAPS ANN EY ANN DY
31-Dec-2021 27-May-2021 31-Mar-2021 1 24,783 1,549 1,444 1,498 - 161,018 - % 5.83% 0.93% 1,110,470 2.23 18.47 0.14 1.12 0.00 0.00 0.1450 1.20   110.71%   127.22% 31-Mar-2021 0.23 10.31 170.50 1.59 0.59% 0.00% 27-May-2021 0.23 10.31 170.50 1.59 0.59% 0.00%
31-Dec-2020 02-Mar-2021 31-Dec-2020 4 16,721 -14,112 -14,215 -13,985 - 157,823 - % -85.01% -8.86% 1,078,027 1.55 12.46 -1.30 -10.42 0.00 0.00 0.1464 1.18   -44.04%   -561.09% 31-Dec-2020 0.28 18.05 -21.58 1.91 -4.63% 0.00% 0.245 15.80 -18.89 1.67 -5.30% 0.00%
31-Dec-2020 27-Nov-2020 30-Sep-2020 3 6,871 -10,441 -10,441 -9,709 - 163,259 - % -151.96% -5.95% 1,037,887 0.66 5.12 -0.94 -7.24 0.00 0.00 0.1573 1.22   -22.40%   -412.69% 30-Sep-2020 0.225 33.99 -24.05 1.43 -4.16% 0.00% 27-Nov-2020 0.315 47.58 -33.67 2.00 -2.97% 0.00%
31-Dec-2020 28-Aug-2020 30-Jun-2020 2 6,392 -8,199 -8,664 -7,932 - 155,173 - % -135.54% -5.11% 916,016 0.70 4.76 -0.87 -5.91 0.00 0.00 0.1694 1.16   -44.14%   -489.97% 30-Jun-2020 0.11 15.76 -12.70 0.65 -7.87% 0.00% 28-Aug-2020 0.30 42.99 -34.65 1.77 -2.89% 0.00%
31-Dec-2020 25-Jun-2020 31-Mar-2020 1 6,532 -5,305 -5,689 -5,503 - 159,138 - % -87.09% -3.46% 860,209 0.76 4.87 -0.64 -4.10 0.00 0.00 0.1850 1.19   -281.44%   -741.38% 31-Mar-2020 0.10 13.17 -15.63 0.54 -6.40% 0.00% 25-Jun-2020 0.12 15.80 -18.76 0.65 -5.33% 0.00%
31-Dec-2019 28-Feb-2020 31-Dec-2019 4 18,413 3,945 3,061 3,033 - 166,079 - % 16.62% 1.83% 860,071 2.14 13.72 0.35 2.26 0.00 0.00 0.1931 1.24   -2.32%   0.43% 31-Dec-2019 0.185 8.64 52.46 0.96 1.91% 0.00% 28-Feb-2020 0.15 7.01 42.54 0.78 2.35% 0.00%
31-Dec-2019 28-Nov-2019 30-Sep-2019 3 17,276 3,516 3,164 3,105 - 163,525 - % 18.31% 1.90% 860,209 2.01 12.87 0.36 2.31 0.00 0.00 0.1901 1.22   52.65%   -26.05% 30-Sep-2019 0.195 9.71 54.02 1.03 1.85% 0.00% 28-Nov-2019 0.195 9.71 54.02 1.03 1.85% 0.00%
31-Dec-2019 30-Aug-2019 30-Jun-2019 2 14,033 2,035 2,028 2,034 - 160,342 - % 14.45% 1.27% 860,209 1.63 10.46 0.24 1.52 0.00 0.00 0.1864 1.19   137.06%   -50.88% 28-Jun-2019 0.20 12.26 84.58 1.07 1.18% 0.00% 30-Aug-2019 0.205 12.57 86.70 1.10 1.15% 0.00%
31-Dec-2019 27-May-2019 31-Mar-2019 1 12,482 1,266 944 858 - 158,536 - % 7.56% 0.54% 860,209 1.45 9.30 0.10 0.64 0.00 0.00 0.1843 1.18   -71.59%   34.06% 29-Mar-2019 0.205 14.13 205.53 1.11 0.49% 0.00% 27-May-2019 0.205 14.13 205.53 1.11 0.49% 0.00%
31-Dec-2018 28-Feb-2019 31-Dec-2018 4 17,313 5,287 3,382 3,020 - 153,288 - % 19.53% 1.97% 832,187 2.08 12.90 0.36 2.25 0.00 0.00 0.1842 1.14   -28.08%   -31.87% 31-Dec-2018 0.21 10.09 57.87 1.14 1.73% 0.00% 28-Feb-2019 0.205 9.85 56.49 1.11 1.77% 0.00%
31-Dec-2018 26-Nov-2018 30-Sep-2018 3 20,182 4,407 4,064 4,199 - 144,089 - % 20.14% 2.91% 809,945 2.49 15.04 0.52 3.13 0.00 0.00 0.1779 1.07   1.40%   33.64% 28-Sep-2018 0.25 10.03 48.22 1.41 2.07% 0.00% 26-Nov-2018 0.24 9.63 46.29 1.35 2.16% 0.00%
31-Dec-2018 23-Aug-2018 30-Jun-2018 2 19,546 4,086 4,006 4,141 890 140,026 21.50% 20.50% 2.96% 809,399 2.41 14.57 0.51 3.09 0.11 0.66 0.1730 1.04   547.03%   67.72% 29-Jun-2018 0.225 9.32 43.98 1.30 2.27% 0.49% 23-Aug-2018 0.265 10.97 51.80 1.53 1.93% 0.42%
31-Dec-2018 28-May-2018 31-Mar-2018 1 12,463 634 603 640 - 135,898 - % 4.84% 0.47% 809,399 1.54 9.29 0.08 0.48 0.00 0.00 0.1679 1.01   -85.56%   132.74% 30-Mar-2018 0.215 13.96 271.91 1.28 0.37% 0.00% 28-May-2018 0.235 15.26 297.20 1.40 0.34% 0.00%
31-Dec-2017 26-Feb-2018 31-Dec-2017 4 18,910 5,858 4,211 4,433 - 135,654 - % 22.27% 3.27% 808,431 2.34 14.09 0.55 3.30 0.00 0.00 0.1678 1.01   41.09%   -2.12% 29-Dec-2017 0.25 10.69 45.59 1.49 2.19% 0.00% 26-Feb-2018 0.235 10.05 42.86 1.40 2.33% 0.00%
31-Dec-2017 27-Nov-2017 30-Sep-2017 3 14,088 3,212 3,120 3,142 714 116,539 22.73% 22.15% 2.70% 714,090 1.97 10.50 0.44 2.34 0.10 0.53 0.1632 0.87   27.26%   12.94% 29-Sep-2017 0.26 13.18 59.09 1.59 1.69% 0.38% 27-Nov-2017 0.26 13.18 59.09 1.59 1.69% 0.38%
31-Dec-2017 23-Aug-2017 30-Jun-2017 2 13,157 2,506 2,456 2,469 - 125,918 - % 18.67% 1.96% 796,451 1.65 9.81 0.31 1.84 0.00 0.00 0.1581 0.94   226.29%   76.99% 30-Jun-2017 0.235 14.23 75.81 1.49 1.32% 0.00% 23-Aug-2017 0.26 15.74 83.87 1.64 1.19% 0.00%
31-Dec-2017 30-May-2017 31-Mar-2017 1 8,631 -2,054 -2,084 -1,955 - 123,008 - % -24.15% -1.59% 782,000 1.10 6.43 -0.25 -1.46 0.00 0.00 0.1573 0.92   -143.17%   -1,702.46% 31-Mar-2017 0.25 22.65 -100.00 1.59 -1.00% 0.00% 30-May-2017 0.245 22.20 -98.00 1.56 -1.02% 0.00%
31-Dec-2016 28-Feb-2017 31-Dec-2016 4 16,762 3,943 4,304 4,529 - 97,639 - % 25.68% 4.64% 666,029 2.52 12.49 0.68 3.38 0.00 0.00 0.1466 0.73   62.80%   18.16% 30-Dec-2016 0.205 8.15 30.15 1.40 3.32% 0.00% 28-Feb-2017 0.23 9.14 33.82 1.57 2.96% 0.00%
31-Dec-2016 22-Nov-2016 30-Sep-2016 3 12,088 2,718 2,668 2,782 - 93,211 - % 22.07% 2.98% 511,029 2.37 9.01 0.54 2.07 0.00 0.00 0.1824 0.69   99.43%   9.01% 30-Sep-2016 0.265 11.20 48.68 1.45 2.05% 0.00% 22-Nov-2016 0.24 10.15 44.09 1.32 2.27% 0.00%
31-Dec-2016 22-Aug-2016 30-Jun-2016 2 11,966 1,379 1,284 1,395 - 90,724 - % 10.73% 1.54% 498,214 2.40 8.92 0.28 1.04 0.00 0.00 0.1821 0.68   1,043.44%   252.27% 30-Jun-2016 0.38 15.82 135.71 2.09 0.74% 0.00% 22-Aug-2016 0.365 15.20 130.36 2.00 0.77% 0.00%
31-Dec-2016 27-May-2016 31-Mar-2016 1 6,908 34 11 122 - 72,915 - % 0.16% 0.17% 406,666 1.70 5.15 0.03 0.09 0.00 0.00 0.1793 0.54   -96.82%   771.43% 31-Mar-2016 0.41 24.14 1,366.67 2.29 0.07% 0.00% 27-May-2016 0.39 22.96 1,300.00 2.18 0.08% 0.00%
31-Dec-2015 26-Feb-2016 31-Dec-2015 4 9,705 4,254 3,820 3,833 - 82,989 - % 39.36% 4.62% 461,566 2.10 7.23 0.88 2.86 0.00 0.00 0.1798 0.62   50.20%   47.37% 31-Dec-2015 0.315 14.98 37.93 1.75 2.64% 0.00% 26-Feb-2016 0.335 15.93 40.34 1.86 2.48% 0.00%
31-Dec-2015 27-Nov-2015 30-Sep-2015 3 8,536 2,534 2,441 2,552 - 75,399 - % 28.60% 3.38% 463,999 1.84 6.36 0.55 1.90 0.00 0.00 0.1625 0.56   544.44%   15.16% 30-Sep-2015 0.275 14.95 50.00 1.69 2.00% 0.00% 27-Nov-2015 0.32 17.39 58.18 1.97 1.72% 0.00%
31-Dec-2015 27-Aug-2015 30-Jun-2015 2 8,252 499 225 396 - 68,947 - % 2.73% 0.57% 439,999 1.88 6.15 0.09 0.30 0.00 0.00 0.1567 0.51   2,728.57%   -77.99% 30-Jun-2015 0.305 16.26 338.89 1.95 0.30% 0.00% 27-Aug-2015 0.27 14.40 300.00 1.72 0.33% 0.00%
31-Dec-2015 15-May-2015 31-Mar-2015 1 3,226 14 -29 14 - 54,115 - % -0.90% 0.03% 361,249 0.89 2.40 0.00 0.01 0.00 0.00 0.1498 0.40   -99.46%   107.61% 0.00 0.00 0.00 0.00 0.00% 0.00% 15-May-2015 0.345 38.63 8,902.23 2.30 0.01% 0.00%
31-Dec-2014 09-Apr-2015 31-Dec-2014 4 8,350 2,698 2,563 2,601 469 53,970 18.06% 30.69% 4.82% 361,249 2.31 6.22 0.72 1.94 0.13 0.35 0.1494 0.40   17.37%   -27.71% 0.00 0.00 0.00 0.00 0.00% 0.00% 0.00 0.00 0.00 0.00 0.00% 0.00%
31-Dec-2014 30-Sep-2014 3 8,069 1,906 2,073 2,216 - - - % 25.69% - % 363,278 2.22 6.01 0.61 1.65 0.00 0.00 - -   23.18%   - % 0.00 0.00 0.00 0.00 0.00% 0.00% 0.00 0.00 0.00 0.00 0.00% 0.00%
31-Dec-2014 30-Jun-2014 2 8,126 2,356 1,836 1,799 - - - % 22.59% - % 359,800 2.26 6.06 0.50 1.34 0.00 0.00 - -   1,077.72%   - % 0.00 0.00 0.00 0.00 0.00% 0.00% 0.00 0.00 0.00 0.00 0.00% 0.00%
31-Dec-2014 31-Mar-2014 1 2,569 -175 -175 -184 - - - % -6.81% - % 367,999 0.70 1.91 -0.05 -0.14 0.00 0.00 - -   -105.11%   - % 0.00 0.00 0.00 0.00 0.00% 0.00% 0.00 0.00 0.00 0.00 0.00% 0.00%
31-Dec-2013 31-Dec-2013 4 12,782 4,683 3,563 3,598 - 48,388 - % 27.88% 7.44% 283,307 4.51 9.53 1.27 2.68 0.00 0.00 0.1708 0.36   - %   - % 0.00 0.00 0.00 0.00 0.00% 0.00% 0.00 0.00 0.00 0.00 0.00% 0.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.


Analyze this stock with MQ Trader system
  13 people like this.
 
Fklim888 LU ka ? Lol
26/07/2021 9:15 AM
Eugene sudden move? any news coming?
26/07/2021 10:23 AM
FaizalHamzah wow/...50cents hahhhhh...miracle..hahaha
26/07/2021 10:56 AM
jupiter can you limit up TT
26/07/2021 12:02 PM
jupiter wa can you go back 0.2
26/07/2021 12:08 PM
Haoger Wakakakakaka nobody cares lel
26/07/2021 4:41 PM
Ginduchti 1 day show again..?
27/07/2021 10:57 AM
BestOne Sometimes, when thing is serious, it will just fly .. so it will ..
27/07/2021 12:23 PM
BestOne Perfect technical ADX widening for uptrend indication, RSI doing active at 70%, very positive green MACD.. perfect take off path…
27/07/2021 12:26 PM
Ginduchti Power of 1 day show, just a slight rebound from 0.19 to 0.225
27/07/2021 5:38 PM
Ginduchti Bankers collecting at 19-20cts level and sell all at 22-22.5cts , simple as that
27/07/2021 5:39 PM
sting79 Ginduchti Bankers collecting at 19-20cts level and sell all at 22-22.5cts , simple as that

Reasonable point, but would also like to point out that not much retailers/traders are buying here due to lack of corporate news/promotions, unstable local scene and just general low market sentiment.

In that case think likely more tickets end up back in the bankers/market makers' hands than being successfully sold to outsiders..
27/07/2021 6:06 PM
fomainre Looking good for Bioalpha this few days, gaining more traction and sign of rebound slowly appearing
28/07/2021 3:36 PM
khpwwl Got show
28/07/2021 7:34 PM
chewysoon82 https://www.theedgemarkets.com/article/bioalpha-seeks-break-south-sudan-covid19-test-market
28/07/2021 8:00 PM
chewysoon82 https://klse.i3investor.com/blogs/leafyresearch/2021-07-28-story-h1568845603-BIOHLDG_0179_A_turn_of_the_tide_supernormal_growth_incoming.jsp
29/07/2021 12:12 AM
BursaMaster121212 i have a friend's friend who attended a briefing hosted by management just now...according to the boss, the revnue from this project is easily more than 200 millions....5% margin also more than 10 million already.....for a small company like bio aplha, it is like making next 5 years profit...easily can limit up few times
29/07/2021 1:33 AM
manager777 https://m.youtube.com/watch?v=4rwaD__Mric
29/07/2021 8:48 AM
kok_wai1985 Wau.... Malaysia, Indonesia and China haven't make good profit in business. Sudah mau pergi Africa buat business. Apa ini? Haha.....
29/07/2021 8:49 AM
kok_wai1985 Mana sales revenue and profit contribution for:
1) CME contract.
2) Ritamix contract.
3) China contract.
4) Covid-19 vaccine.
5) Paling latest, Africaaaaa...... Haha....
29/07/2021 8:56 AM
kok_wai1985 For South Sudan, makan pun dah susah and always war. Lagi mau cakap sell Covid-19 test kit and upplement product. Apa la ni......
29/07/2021 9:04 AM
jupiter any suggest bio-wa wan cut?
29/07/2021 9:19 AM
Kongkalikong poor country..WHO pay for testing and vaccine..no need to worry. Company in international trade knows how to protect their interest. Sudan cannot pay kira bad debt so Bio can claim sudan and send some of the investor who talk talk t
o stay there..lol
29/07/2021 10:21 AM
Ginduchti Business ventures into South Africa, so as the price!! To the south !!

Warrant 6cts, 5 cts coming after force selling!!
29/07/2021 10:55 AM
858411123 Read this article larrr .. just look at the profit growth

https://klse.i3investor.com/blogs/leafyresearch/2021-07-28-story-h1568845603-BIOHLDG_0179_A_turn_of_the_tide_supernormal_growth_incoming.jsp
29/07/2021 11:08 AM
858411123 Mcm mane nk pergi south? profit intact!
29/07/2021 11:08 AM
deepseavalue those who cant went go south la.. hehehehe
29/07/2021 11:08 AM
deepseavalue operator depressing price for collection? hehehe .. always good sign to see people here, normally sure spike after 1 week or 2
29/07/2021 11:11 AM
uchiha1 Yes.. always they coming out and share price spike xD
29/07/2021 11:18 AM
limyeesee https://www.theedgemarkets.com/article/bioalpha-seeks-break-south-sudan-covid19-test-market

KUALA LUMPUR (July 28): Bioalpha Holdings Bhd has partnered a laboratory in South Sudan to undertake a Covid-19 testing programme at the border entry points in the country.

The health supplement group said in a filing that its wholly-owned subsidiary Bioalpha (HK) Ltd (Bioalpha HK) had entered into a memorandum of agreement (MoA) with Crawford Laboratory of the Republic of South Sudan to exclusively undertake the Covid-19 testing programme.

The mandate involves installation of testing facilities, as well as the provision of testing products and services at border entry points in the country to screen all inbound travellers to South Sudan at these locations to prevent cross-border infections.

According to Bioalpha, this collaboration is part of the initiative by the East African Community (EAC) to make available Covid-19 testing products and services to the 180 million population in six partner countries.

Apart from South Sudan, the other countries are Kenya, Rwanda, the United Republic of Tanzania, the Republic of Uganda and the Republic of Burundi.

Crawford Laboratory is principally involved in the provision of Covid-19 testing activities in South Sudan and is currently the only organisation in the country offering online applications for Covid-19 tests.

Under the MoA, Bioalpha HK will supply the necessary equipment and the training required to properly utilize the said equipment for the purpose of the Covid-19 testing programme.

Bioalpha HK will supply 100,000 test kits per month along with its consumables, and the testing cost to be charged to travellers is at approximately US$20 (RM85) for locals and US$50 (RM212) for foreigners.

Meanwhile, Crawford Laboratory will manage the testing facilities and liaise with the necessary authorities within South Sudan to ensure all inbound travellers to the country via the Nimule and Juba International Airport are compulsorily required to take the Covid-19 test under the programme.

It will also obtain the necessary regulatory approvals required for the programme.

The MoA will come into effect on the date of signing and will remain in effect for a period of two years from the date of signing of the MoA subject to a further renewal based on both parties' mutual agreement.

Bioalpha said the MoA enables the company to widen its revenue streams to include the distribution of Covid-19 screening equipment and products to nations under the EAC, starting with South Sudan, which has a population of 11 million people.

“In addition, this programme would also pave way and serve as a platform for Bioalpha to expand the delivery of other healthcare and pharmaceutical products and services to South Sudan as well as other partner states under the EAC,” it said, adding that this opens up a whole new market for Bioalpha as it establishes its presence in the EAC nations.

The MoA is expected to contribute positively towards the future earnings of Bioalpha, the company said.

Bioalpha closed 0.5 sen or 2.27% higher at 22.5 sen today, valuing the group at RM260.59 million.
29/07/2021 3:25 PM
limyeesee Seems that coming QR , bioalpha will reflect a good outcome
29/07/2021 3:26 PM
Buy high Sell low Bioalpha turn to boom?? 200m revenue, not sure how much bioalpha can get
29/07/2021 3:26 PM
wayneforwin This stock seems like not many people looking good in it. Supplement with test kids seem good combination, which is having a big opportunity to expand.
29/07/2021 3:33 PM
jazmaster Vaccine is one dose or two dose but test kits maybe require more than as for checking purpose, guess the demand is there and there are a huge demand that will profit to bioholding. Let see how coming QR will reflected on it
29/07/2021 3:40 PM
nasilemak5 Seems like a lot of people sell on news, but not heavy sell down, seems good, Technical is forming and now additional with news now. Sooner or later sure goreng one wave. Good timing to invest some share in it.
29/07/2021 3:43 PM
value8888 Incoming got show ?
29/07/2021 3:47 PM
240gpark The research seems proven and good. Guess bioalpha is coming soon. If short term goreng failed and drag next two qr.
29/07/2021 3:57 PM
value8888 Road to 30 cent !
29/07/2021 3:59 PM
seriusinvestor Confirm got show, this project will open more windows for more deals in that region
29/07/2021 4:00 PM
Ginduchti Probably sideway in the next 2-3 weeks before another pump. Best is to buy the dip
29/07/2021 5:50 PM
davidts95 Seems good... Limit up mou ?
30/07/2021 12:58 PM
Ginduchti Let it drop further first, T3 today
30/07/2021 2:56 PM
seriusinvestor Limit up? not so soon..... can keep on collecting first
30/07/2021 4:01 PM
Ginduchti At least 2 more weeks of sideway, dont have to collect in a rush
31/07/2021 11:22 AM
chewysoon82 https://klse.i3investor.com/blogs/mwq78821/2021-07-31-story-h1568901531-Queries_on_Bursa_Malaysia_to_BIOHLDG_KLSE_0179.jsp
31/07/2021 9:14 PM
khpwwl sideway at least another 7 days
02/08/2021 9:33 AM
shavemyfurm Invest BIOALPHA HOLDINGS ?
Ini kalilah !!!
02/08/2021 11:25 AM
shavemyfurm Engine heated up
02/08/2021 11:25 AM
skylimit88 where is the limit ? Sky is the limit ! haut ah, heng ah, ong ah !
02/08/2021 11:26 AM
penjohor Big windows awaiting for Bioalpha, might be limit up? or more covid-19 testing project incoming??
02/08/2021 3:15 PM